EP3909966
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
17.4.2014:
9.7.2025:
21178047.3
:
16.4.2034:
16.4.2026
:
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY
17.4.2014
9.7.2025
16.4.2026
:
Sage Therapeutics, Inc.:
55 Cambridge Parkway, Cambridge, MA 02142, US
:
BOTELLA, Gabriel Martinez:
Wayland, 01778, US
:
HARRISON, Boyd L.:
Princeton Junction, 08550, US
:
ROBICHAUD, Albert Jean:
New Jersey, 08551, US
:
SALITURO, Francesco G.:
Marlborough, 01752, US
:
BERESIS, Richard Thomas:
Shanghai, 200040, CN
:
PCT/CN2013/074323:
17.4.2013:
WO
:
C07J 43/00, A61K 31/57, A61K 31/573, A61K 31/58, A61P 25/00, A61P 9/00, A61P 25/04, A61P 25/08, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/28, A61P 25/30, A61P 27/16, A61P 25/14, C07J 3/00, C07J 7/00, C07J 15/00, C07J 1/00, C07J 5/00, C07J 13/00, C07J 21/00, C07J 31/00